Concepedia

DOLORES M. PIRNIK

DM

Statistics

Publications

11

Citations

605

H-Index

11

Active since

1992

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Instytut Farmaceutyczny

Bristol-Myers Squibb (Sweden)

DOLORES M. PIRNIK is an author at Bristol-Myers Squibb (United States) specializing in life sciences, drug discovery, and medicinal chemistry.

Publications per year

1992–1999

11

Publications

11

Bacillaene, a Novel Inhibitor of Procaryotic Protein Synthesis Produced by Bacillus subtilis: Production, Taxonomy, Isolation, Physico-chemical Characterization and Biological Activity.

Pramathesh S. Patel, Stella Huang, DOLORES M. PIRNIK et al. · The Journal of Antibiotics · 1995 · 207 citations · Full text

, , +10

Eupenifeldin, a novel cytotoxic bistropolone from Eupenicillium brefeldianum.

Friedrich Mayerl, Qi Gao, Stella Huang et al. · The Journal of Antibiotics · 1993 · 65 citations · Full text

, , +4

Fusaricide, a New Cytotoxic <i>N</i>-Hydroxypyridone from <i>Fusarium </i>sp.

KIMBERLY D. MCBRIEN, Qi Gao, Stella Huang et al. · Journal of Natural Products · 1996 · 56 citations

, , +4

BMS-182123, a Fungal Metabolite that Inhibits the Production of TNF-.ALPHA. by Macrophages and Monocytes.

Glenn A. Warr, Judith A. Veitch, Ann W. Walsh et al. · The Journal of Antibiotics · 1996 · 51 citations

, , +12

Orevactaene,1 a novel binding inhibitor of HIV-1 rev protein to Rev response element (RRE) from Epicoccum nigrum WC47880

Yue‐Zhong Shu, Qingmei Ye, Hui Li et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 49 citations

, , +13

1–5 of 11